Dual-stiffness nanoparticles for compartment-specific drug delivery in stroke

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Neuroscience

Background:

• Ischemic stroke involves complex inflammation in both the peripheral immune system and the central nervous system.
• Conventional treatments often fail to address this dual-compartment pathology effectively.
• A need exists for targeted therapies that can modulate both systemic and central nervous system responses.

Purpose of the Study:

• To develop a spatially tiered drug delivery system using dual-stiffness nanoparticles for targeted ischemic stroke intervention.
• To investigate the mechanism of stiffness-dependent nanoparticle biodistribution.
• To demonstrate synergistic peripheral-central therapeutic effects via a single administration.

Main Methods:

• Fabrication of dual-stiffness nanoparticles (NPs).
• Assessment of NP biodistribution based on stiffness.
• Delivery of anti-inflammatory agents to peripheral immune cells and neuroprotectants to the brain.
• Mechanistic studies involving membrane energetics and protein adsorption.

Main Results:

• Stiff NPs preferentially targeted peripheral immune cells, reducing systemic inflammation.
• Soft NPs successfully penetrated the brain to deliver neuroprotective agents.
• The differential distribution was attributed to NP stiffness-mediated interactions with biological components.
• Synergistic therapeutic effects were observed in a single administration.

Conclusions:

• Dual-stiffness nanoparticles enable compartment-specific drug delivery for ischemic stroke.
• This mechano-guided nanomedicine strategy offers a paradigm for treating multi-compartment diseases.
• The approach holds significant potential for precision therapeutic interventions.